‘Dotun Oyenuga, RPh, PhD, MSE

Founder and CEO at The Pharmaceutic Associates Inc,
Managing Pharmacist and Principal Pharmacoengineer,                                                                                                                                                                           
Medicineers at USPharmaceutica, Plano, Texas

The Professional

Dr. K. OlaDotun Oyenuga obtained his Pharmacy Degree (BPharm.) MS and PhD (Pharmaceutics and Industrial Pharmacy) from the University of Ibadan in Ibadan, Nigeria. He continued his Postdoctoral Education in Clinical Pharmacology at the National Institutes of Health – Clinical Center in Bethesda, Maryland and in Molecular Neurology and Neuropathy at the Cold Spring Harbor Laboratory in Cold Spring Harbor, New York. After this, he attended the University of Pennsylvania – Penn Engineering and the Wharton School –in Philadelphia, Pennsylvania to obtain his MSE in Technology Management.

Throughout his rich and diverse work history, Dr. Oyenuga held positions as a lecturer and Assistant Professor in Pharmaceutics and Industrial Pharmacy, was a Postdoctoral Research Associate in Pharmaceutical Sciences at the University of the Sciences in Philadelphia and a Senior Scientist and Director in Product Development. For several retail pharmacies, he held positions as a Staff Pharmacist and Pharmacy Manager. Additionally, he was also an IV medication and Chemotherapy Pharmacist for a medical center.

Most of his research work, publications he has written and the presentations he has given focus on engineering of nanocarriers for advanced drug delivery applications and neurogenic drug profiling. In addition, Dr. Oyenuga is a member of the American Association of Pharmaceutical Scientists.

Beginning in 2009, Dr. Oyenuga became the founder and CEO of several companies including The Pharmaceutic Associates  (Medicineers at USPharmaceutica) in the North Dallas area and Associated Chemists and Technology Managers in Philadelphia area.

Medicineers at USPharmaceutica is a USP <795>  licensed pharmacy in Texas.

Dr. Ola’s interests include Clinical Research and Trials, R&D, and Risk Management. Additionally, he holds interests in all areas of functional, integrative and holistic medicine. His goal is to problem solve and collaborate with physicians for optimal results for his clients and to meet the unique needs of patients and their practitioners with the highest principles and dedication.

Dr. Oyenuga utilizes genetic testing as an integrative strategy to bridge the gap between traditional practitioners and a more naturopathic and functional approach to health and wellness.

The Everyday Man
In his leisure time, Ola enjoys competitive sports, staying abreast of world news as well as exploring new foods and restaurants.  He is an avid chess player and indulges in listening to various genres of music.  He enjoys traveling and spending time with his family.  Atop his leisure activities, he enjoys spending time with his wife, Candace Marie and their two young sons.

Enitan Bababunmi, PhD, DSc.
The Pharmaceutics Associates Founding Consultant

Enitan Bababunmi is the Founder & President of ENHICA-Research International, Inc. Since 1970 he has focused on mitochondrial bioenergetics and calcium uptake, cancer and toxicological studies among other medical issues. He has been a consultant all his career and from 1977-1997, he contributed to the work of International Programs on Chemical Safety at the World Health Organization. Enitan is the Founder and Executive Chairman of the company as well. He has gotten great grant support over the years from several academic foundations including the Rockeller Foundation, The Royal Society, UK, the Eleanor Roosevelt Foundation and the American Cancer Society. Enitan is a fellow of the Royal Society of Medicine, UK since 2001, and has been published many times.

Education:
FRCPath Toxicology- Royal College of Pathologists, UK
DSc- Toxicology- University of London, UK
PhD-Tropical Toxicology- University of Ibadan, Ibadan, Nigeria
BSc- Biochemistry- University College, London, UK